Related Experiment Videos

Microglia in human disease, with an emphasis on acquired immune deficiency syndrome

D W Dickson1, L A Mattiace, K Kure

  • 1Department of Pathology, Neuropathology, Albert Einstein College of Medicine, Bronx, NY 10461.

Insights

Microglia are the main sites of active Human Immunodeficiency Virus type 1 (HIV-1) infection in the central nervous system (CNS). This infection may disrupt CNS homeostasis and impact neuronal and glial cells, potentially mediated by cytokines.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • The central nervous system (CNS) is a primary target for Human Immunodeficiency Virus type 1 (HIV-1) infection.
  • Microglia, the resident immune cells of the CNS, are increasingly recognized as key players in HIV-1 neuropathogenesis.

Purpose of the Study:

  • To elucidate the primary sites of active HIV-1 infection within the CNS.
  • To explore the mechanisms of HIV-1 entry and activation within microglia.
  • To understand the consequences of microglial HIV-1 infection on CNS homeostasis and cellular function.

Main Methods:

  • The study synthesizes existing evidence on HIV-1 infection within the CNS.
  • It examines the role of monocyte infiltration and microglial turnover in viral dissemination.
  • It discusses the influence of microglial differentiation, cytokines, and co-infections on viral activation.

Main Results:

  • Overwhelming evidence indicates microglia are the primary sites of active HIV-1 infection in the CNS.
  • HIV-1 may enter the CNS via monocytes, which differentiate into microglia.
  • Microglial infection can disrupt the balance between microglia, other glia, and neurons.

Conclusions:

  • Microglial infection by HIV-1 is a critical factor in CNS pathogenesis.
  • Cytokines are implicated as mediators of adverse effects on CNS cells, myelin, and endothelial cells.
  • The impact on synaptic integrity remains an area for future research.

Related Concept Videos